ClinicalTrials.gg
Status unknownNCT05995483BreastSelfExamUpdated Aug 16, 2023

Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day

An interventional study of Early Diagnosis on BSE in Breast Self-Examination, Breast Cancer and Nursing Caries, sponsored by Eastern Mediterranean University. Status unknown at 1 site in Cyprus. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-16.

Sponsored by Eastern Mediterranean University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2023), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2023, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

H0: Among the intervention and control groups of reminder notifications relating to self-examination

H01: Average breast cancer fear score and H02: There is no difference in the average score of breast cancer health beliefs.

H1: Among the intervention and control groups of reminder notifications relating to self-examination

H11: Average breast cancer fear score H12: Breast cancer is different in terms of average score of health beliefs

Read the detailed description

Newly Enrolled Students in the Nursing Programs at Girne American University and Eastern Mediterranean University Will Participate in This Study as an Experimental Study With a Pretest/Posttest Control Group. The Students Will Receive the Same Training. Contrary to the Control Group, the Intervention Group Will Have the System Which Will Send Reminder Notifications (Via the Web Base) Directing Them to the Website Containing BSE Training, Along With the Vector Illustration to be Created for the Concurrent Practice Prepared by the Researcher on the Determined Ideal Day. Users Will Receive a Notification Twice Via the Website and Email That Includes Re-examination Seven Days Following the End of Their Period. Depending on the Permission They Grant to Their Phones, Users Will be Able to Access the BSE Training Materials on the Website by Clicking on the General Reminder Notification or the Router, Using Their Browsers, and Logging in to Their Accounts. The Data on the Frequency of BSE With the "Breast Cancer Fear Scale" and "Champion's Health Belief Model Scale" Will be Collected From the Users at the End of the Three-month Period of Using the Website, Which Will be Developed in Order to Raise the Chances of Early Diagnosis by Encouraging BSE.

02

Conditions studied

  • Breast Self-Examination
  • Breast Cancer
  • Nursing Caries
  • Cancer
  • Awakening Early

Keywords

  • Awareness
  • Early Diagnosis
  • Prevent Surgery
  • Breast Self-Examination
03

In context

Breast Neoplasms

12,815 studies on the registry are indexed under Breast Neoplasms; 2,920 are open to participants now.

This study's enrollment of 76 is close to the median of 72 across 9,494 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Eastern Mediterranean University is the lead sponsor of 141 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Who is over 18 years old,
  • Eastern Mediterranean University and Girne American University, newly enrolled female students in the Nursing Department of the Faculty of Health Sciences

Exclusion criteria

Exclusion Criteria:

  • People who do not meet the criteria
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (actual)

Study arms

  • Experimental
    Have access to web based BSE training and notifications

    Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day.

    Other: Early Diagnosis on BSE

  • No intervention
    Has no intervention during the study

    Only has an powerpoint training og BSE, not knowing about the web base system

Interventions

  • OtherEarly Diagnosis on BSE

    the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day.

06

What researchers measure

Primary outcomes

  1. Change in the health belief scores on 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale' related web based BSE examination notifications in 3 months.

    Measuring the health belief on breast cancer early diagnosis and awareness with web based bse training and notifications using 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale'.

    Time frame: 3 months

07

Study locations

1 site
  • Eastern Mediterranean University & Girne American University
    Kyrenia, Cyprus
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05995483
Responsible party
Sponsor
First posted
Aug 16, 2023
Start date
Apr 4, 2023
Primary completion
Sep 4, 2023 (estimated)
Completion
Sep 4, 2023 (estimated)
Last update
Aug 16, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion